New Meta-analysis Backs Efficacy in nccRCC A new systematic review and meta-analysis have reinforced the growing evidence base for immunotherapy-based...
Vous n'êtes pas connecté
Australian-led trial delivers encouraging results. A landmark Australian-led phase 2 clinical trial has delivered promising results for patients with advanced gynecological clear cell cancers (CCCs), a rare and aggressive group of malignancies that historically respond poorly to standard chemotherapy. The MoST-CIRCUIT study, a prospective multicentre trial conducted across 17 sites in Australia and New Zealand, [...]
New Meta-analysis Backs Efficacy in nccRCC A new systematic review and meta-analysis have reinforced the growing evidence base for immunotherapy-based...
Australian researchers have demonstrated that the use of a new, less toxic drug combination after stem cell transplants for leukaemia significantly...
The official results of the BRACELET-01 (PrECOG 0113) trial have been published in Clinical Cancer Research, detailing the safety and efficacy of...
Using real-world data, Mass General Brigham researchers reveal how the combination of two blood cancer medications can improve outcomes for patients...
Using real-world data, Mass General Brigham researchers reveal how the combination of two blood cancer medications can improve outcomes for patients...
By Lakshmy Ramakrishnan Biotechnology is a critical emerging technology holding significant potential in addressing various challenges,...
A new study offers fresh hope for people diagnosed with glioblastoma, one of the most aggressive and deadly brain cancers. Researchers at Keck...
Laboratory tests have shown promising results in the treatment of 25 cancers. ......
Laboratory tests have shown promising results in the treatment of 25 cancers. ......